15-42384511-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP5
The NM_000070.3(CAPN3):āc.338T>Cā(p.Ile113Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000262 in 1,613,914 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000070.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN3 | NM_000070.3 | c.338T>C | p.Ile113Thr | missense_variant | Exon 2 of 24 | ENST00000397163.8 | NP_000061.1 | |
CAPN3 | NM_024344.2 | c.338T>C | p.Ile113Thr | missense_variant | Exon 2 of 23 | NP_077320.1 | ||
CAPN3 | NM_173087.2 | c.338T>C | p.Ile113Thr | missense_variant | Exon 2 of 21 | NP_775110.1 | ||
LOC105370794 | XR_932178.3 | n.*36A>G | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.338T>C | p.Ile113Thr | missense_variant | Exon 2 of 24 | 1 | NM_000070.3 | ENSP00000380349.3 | ||
ENSG00000258461 | ENST00000495723.1 | n.*134T>C | non_coding_transcript_exon_variant | Exon 6 of 26 | 2 | ENSP00000492063.1 | ||||
ENSG00000258461 | ENST00000495723.1 | n.*134T>C | 3_prime_UTR_variant | Exon 6 of 26 | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251430Hom.: 0 AF XY: 0.0000957 AC XY: 13AN XY: 135880
GnomAD4 exome AF: 0.000276 AC: 403AN: 1461706Hom.: 1 Cov.: 30 AF XY: 0.000232 AC XY: 169AN XY: 727172
GnomAD4 genome AF: 0.000131 AC: 20AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74350
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:4
- -
- -
PM3 -
Available data are insufficient to determine the clinical significance of the variant at this time. The frequency of this variant in the general population is uninformative in assessment of its pathogenicity. (http://gnomad.broadinstitute.org) This variant has been identified in at least one individual with clinical features associated with this gene. Polyphen and MutationTaster yielded discordant predictions regarding whether this amino acid change is damaging to the protein. -
Identified in the presence of a second CAPN3 variant, in a patient with early onset pelvifemoral LGMD2A, however CAPN3 enzyme deficiency was not detected (PMID: 25079074); Identified heterozygous by NGS panel testing in three patients with LGMD2A, however no second variant was identified (PMID: 30564623); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23553538, 25079074, 30564623) -
Autosomal recessive limb-girdle muscular dystrophy type 2A Pathogenic:1Uncertain:2
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 113 of the CAPN3 protein (p.Ile113Thr). This variant is present in population databases (rs747026964, gnomAD 0.02%). This missense change has been observed in individual(s) with limb-girdle muscular dystrophy (PMID: 23553538, 25079074, 30564623). ClinVar contains an entry for this variant (Variation ID: 283107). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CAPN3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
- -
Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
- -
not specified Uncertain:1
Variant summary: CAPN3 c.338T>C (p.Ile113Thr) results in a non-conservative amino acid change located in the Peptidase C2, calpain, catalytic domain (IPR001300) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 9.1e-05 in 251430 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in CAPN3 causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (9.1e-05 vs 0.0032), allowing no conclusion about variant significance. c.338T>C has been reported in the literature as a compound heterozygous genotype in at-least one individual affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (example, Nilsson_2014) and as a VUS with a non-informative genotype (second allele not specified) in at-least three individuals within a cohort sequenced for Limb-girdle muscular dystrophies (LGMDs) at a reference laboratory (example, Nallamilli_2018). These data do not allow any conclusion about variant significance. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (Likely pathogenic, n=1; VUS, n=4). Based on the evidence outlined above, the variant was classified as uncertain significance. -
CAPN3-related disorder Uncertain:1
The CAPN3 c.338T>C variant is predicted to result in the amino acid substitution p.Ile113Thr. This variant has been reported in multiple individuals with limb-girdle muscular dystrophy; however, it is not clear if a second CAPN3 variant was identified in some of these patients (Table S7, Nallamilli et al. 2018. PubMed ID: 30564623; Table 1, Nilsson et al. 2014. PubMed ID: 25079074). This variant is reported in 0.022% of alleles in individuals of European (non-Finnish) descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at